Akhtar Aysha Z, Pippin John J, Sandusky Chad B
Physicians Committee for Responsible Medicine, Washington, DC, USA.
Altern Lab Anim. 2009 Feb;37(1):43-62. doi: 10.1177/026119290903700108.
The objective of this study was to examine whether animal studies can reliably be used to determine the usefulness of methylprednisolone (MP) and other treatments for acute spinal cord injury (SCI) in humans. This was achieved by performing a systematic review of animal studies on the effects of MP administration on the functional outcome of acute SCI. Data were extracted from the published articles relating to: outcome; MP dosing regimen; species/strain; number of animals; methodological quality; type of injury induction; use of anaesthesia; functional scale used; and duration of follow-up. Subgroup analyses were performed, based on species or strain, injury method, MP dosing regimen, functional outcome measured, and methodological quality. Sixty-two studies were included, which involved a wide variety of animal species and strains. Overall, beneficial effects of MP administration were obtained in 34% of the studies, no effects in 58%, and mixed results in 8%. The results were inconsistent both among and within species, even when attempts were made to detect any patterns in the results through subgroup analyses. The results of this study demonstrate the barriers to the accurate prediction from animal studies of the effectiveness of MP in the treatment of acute SCI in humans. This underscores the need for the development and implementation of validated testing methods.
本研究的目的是检验动物研究是否能够可靠地用于确定甲基强的松龙(MP)及其他治疗方法对人类急性脊髓损伤(SCI)的有效性。这是通过对关于MP给药对急性SCI功能结局影响的动物研究进行系统评价来实现的。数据从已发表的文章中提取,涉及:结局;MP给药方案;物种/品系;动物数量;方法学质量;损伤诱导类型;麻醉的使用;所使用的功能量表;以及随访持续时间。基于物种或品系、损伤方法、MP给药方案、所测量的功能结局以及方法学质量进行亚组分析。纳入了62项研究,涉及多种动物物种和品系。总体而言,34%的研究获得了MP给药的有益效果,58%无效果,8%结果不一。即使试图通过亚组分析在结果中发现任何模式,结果在物种间和物种内均不一致。本研究结果表明了动物研究准确预测MP治疗人类急性SCI有效性的障碍。这突出了开发和实施经过验证的测试方法的必要性。